Fintel on MSN

Leerink Partners Maintains Quest Diagnostics (DGX) Outperform Recommendation

Fintel reports that on October 21, 2025, Leerink Partners maintained coverage of Quest Diagnostics (NYSE:DGX) with a ...
TipRanks on MSN

Quest Diagnostics price target raised to $215 from $200 at Jefferies

Jefferies raised the firm’s price target on Quest Diagnostics (DGX) to $215 from $200 and keeps a Buy rating on the shares. Sales and EPS beat ...
Business Insider

Quest Diagnostics price target raised to $198 from $190 at BofA

BofA analyst Michael Ryskin raised the firm’s price target on Quest Diagnostics (DGX) to $198 from $190 and keeps a Buy rating on the shares. Sentiment for Life Sciences and Diagnostic Tools and ...
Business Insider

Quest Diagnostics price target raised to $189 from $178 at Mizuho

Mizuho raised the firm’s price target on Quest Diagnostics (DGX) to $189 from $178 and keeps an Outperform rating on the shares. The firm surveyed 215 physicians over 13 specialties to gauge hospital ...
Nasdaq

Bluejay Diagnostics (BJDX) Price Target Increased by 1900.00% to 61.20

The average one-year price target for Bluejay Diagnostics (NASDAQ:BJDX) has been revised to 61.20 / share. This is an increase of 1,900.00% from the prior estimate of 3.06 dated July 5, 2023. The ...